, Tracking Stock Market Picks
Enter Symbol:
Salix Pharmaceuticals, Ltd. (SLXP) [hlAlert]

up 152.87 %

Salix Pharmaceuticals, Ltd. (SLXP) rated Buy by Buckingham Research

Posted on: Wednesday,  Jun 12, 2013  9:25 AM ET by Buckingham Research

Buckingham Research rated Buy Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) on 06/12/2013, when the stock price was $66.99. Since
then, Salix Pharmaceuticals, Ltd. has gained 152.87% as of 03/31/2015's recent price of $169.40.
If you would have followed this Buckingham Research's recommendation on SLXP, you would have gained 152.87% of your investment in 657 days.

Salix Pharmaceuticals, Ltd. objective is to be a market-driven specialtypharmaceutical company focussed on the needs of physicians specializing ingastroenterology. The company intends to establish a small direct sales force to promote its products to this specialist audience. The company's strategy is to identify and acquire products that have near-term commercial potential and apply its regulatory and product development expertise to commercialize these products. The company selects products that it believes serve a gastrointestinal disease.

Buckingham Research
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/12/2013 9:25 AM Buy
as of 12/13/2013
1 Week down  -2.82 %
1 Month down  -1.51 %
3 Months up  25.22 %
1 YTD up  25.46 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy